Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2009 Feb 19:10:23.
doi: 10.1186/1471-2474-10-23.

Point mutation of tyrosine 759 of the IL-6 family cytokine receptor, gp130, augments collagen-induced arthritis in DBA/1J mice

Affiliations

Point mutation of tyrosine 759 of the IL-6 family cytokine receptor, gp130, augments collagen-induced arthritis in DBA/1J mice

Fumio Tsuji et al. BMC Musculoskelet Disord. .

Abstract

Background: Knock-in mice (gp130F759) with a Y759F point mutation in gp130, a signal transducing receptor subunit shared by members of the IL-6 cytokine family, show sustained activation of STAT3, enhanced acute-phase or immune responses, and autoimmune arthritis. We conducted a detailed analysis of collagen-induced arthritis (CIA) in gp130F759 with a DBA/1J background (D/J.gp130F759).

Methods: We backcrossed gp130F759 to C57BL/6 and DBA/1J, and compared the pathologic changes, including occurrence of arthritis, in the two distinct genetic backgrounds. We analyzed CIA in D/J.gp130F759 and investigated the effects of methotrexate (MTX) on CIA.

Results: C57BL/6 background gp130F759 mice, but not D/J.gp130F759, spontaneously developed polyarthritis and glomerulonephritis. On the other hand, keratitis of the eyes only developed in D/J.gp130F759, indicating the influence of genetic background on disease development in gp130F759 mice. Resistance of the DBA/1J background against spontaneous arthritis urged us to examine CIA in D/J.gp130F759. CIA in D/J.gp130F759 was more severe, with greater bone destruction, than the control mice. After collagen immunization, splenomegaly and serum levels of rheumatoid factor and anti-DNA antibody were augmented in D/J.gp130F759. Bio-Plex analysis of serum cytokines revealed increased IL-12p40 and PDGF-BB before immunization, and increased levels of IFN-gamma, IL-17, TNF-alpha, IL-9, and MIP-1beta 8 days after the booster dose. IL-6 and PDGF-BB in D/J.gp130F759 showed distinct kinetics from the other cytokines; higher levels were observed after arthritis development. MTX partially attenuated the development of arthritis and inhibited bone destruction in D/J.gp130F759, with reduction of anti-type II collagen antibody levels, suggesting that MTX mainly affects antigen-specific immune responses in CIA.

Conclusion: The Tyr-759 point mutation of the IL-6 family cytokine receptor subunit, gp130, caused autoimmune disease, and this was also influenced by the genetic background. CIA in D/J.gp130F759 is useful for evaluating drugs in a relatively short period because sustained activation of STAT3 may enhance the disease symptoms.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Severe arthritis developed in gp130F759 mice by collagen immunization. D/J.gp130F759 and wild-type mice were injected intradermally with collagen emulsified in FCA on day 0 and day 14. Values are expressed as mean ± standard error of 7 to 10 animals. *P < 0.05, **P < 0.01 versus wild-type mice by Student's t-test.
Figure 2
Figure 2
Marked splenomegaly in CIA of D/J.gp130F759 mice. Values are expressed as mean ± standard error of 7 to 10 animals of collagen-immunized mice on day 56 (a) and 3 to 4 animals of non-immunized mice (b). *P < 0.05, **P < 0.01 versus wild-type mice by Student's t-test.
Figure 3
Figure 3
Increased serum levels of rheumatoid factor in CIA of D/J.gp130F759 mice. Values are expressed as mean ± standard error of 7 to 10 animals of collagen-immunized mice on day 56 (a) and 3 to 4 animals of non-immunized mice (b). *P < 0.05, **P < 0.01 versus wild-type mice by Student's t-test.
Figure 4
Figure 4
Increased serum levels of anti-ssDNA antibody in CIA of D/J.gp130F759 mice. Values are expressed as mean ± standard error of 7 to 10 animals of collagen-immunized mice on day 56 (a) and 3 to 4 animals of non-immunized mice (b). *P < 0.05, **P < 0.01 versus wild-type mice by Student's t-test.
Figure 5
Figure 5
Serum levels of anti-collagen antibody in CIA of D/J.gp130F759 mice on day 56. Values are expressed as mean ± standard error of 7 to 10 animals on day 56. *P < 0.05 versus wild-type mice by Student's t-test.
Figure 6
Figure 6
Serum cytokines that showed different responses in D/J.gp130F759 mice (female). Serum cytokine levels were measured by Bio-Plex system. Values are expressed as mean ± standard error of 7 to 10 animals. *P < 0.05, **P < 0.01 versus wild-type mice at same day by Student's t-test.
Figure 7
Figure 7
IL-2 production in lymph node cells of D/J.gp130F759 mice (female) by collagen and concanavalin A stimulation. Values are expressed as mean ± standard error of 12 samples. **P < 0.01 versus non-treated group (Spon) by Student's t-test. #P < 0.05, ## P < 0.01 versus same condition group of wild type mice-derived lymph node cells by Student's t-test.
Figure 8
Figure 8
Methotrexate attenuated CIA (a), and delayed the onset of arthritis (b) in gp130F759 mice (male). Values are expressed as mean ± standard error of 11 to 12 animals. *P < 0.05, **P < 0.01 versus vehicle-treated group by Student's t-test. aP < 0.05, aaP < 0.01 versus Non-immunized group by Student's t-test.
Figure 9
Figure 9
Methotrexate attenuated the increase of COMP levels (a) and anti-collagen antibody levels (b) in the serum on day 42. Values are expressed as mean ± standard error of 11 to 12 animals. *P < 0.05, **P < 0.01 versus vehicle-treated group by Student's t-test. aaP < 0.01 versus Non-immunized group (NI) by Student's t-test.

Similar articles

Cited by

References

    1. Firestein GS. Evolving concepts of rheumatoid arthritis. Nature. 2003;423:356–361. - PubMed
    1. Feldmann M, Brennan FM, Maini RN. Role of cytokines in rheumatoid arthritis. Annu Rev Immunol. 1996;14:397–440. - PubMed
    1. McInnes IB, Liew FY. Cytokine networks-towards new therapies for rheumatoid arthritis. Nat Clin Pract Rheumatol. 2005;1:31–39. - PubMed
    1. Hirano T. Interleukin 6 and its receptor: ten years later. Int Rev Immunol. 1998;16:249–284. - PubMed
    1. Hirano T, Taga T, Yasukawa K, Nakajima K, Nakano N, Takatsuki F, Shimizu M, Murashima A, Tsunasawa S, Sakiyama F, Kishimoto T. Human B-cell differentiation factor defined by an anti-peptide antibody and its possible role in autoantibody production. Proc Natl Acad Sci USA. 1987;84:228–231. - PMC - PubMed

MeSH terms

LinkOut - more resources